Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
HIV Clinical Trials|June 29, 2005
Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in ItalyJohn Hornberger, Jesse Green, Neil Wintfeld, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|March 21, 2012
HIV-related stigma, isolation, discrimination, and serostatus disclosure: a global survey of 2035 HIV-infected adultsJean B Nachega, Chelsea Morroni, José M Zuniga, et al.
Deutsches Arzteblatt International|March 16, 2011
HIV and cancer in GermanyManfred Hensel, Armin Goetzenich, Thomas Lutz, et al.
AIDS (London, England)|May 29, 2004
Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendationsBonaventura Clotet, François Raffi, David Cooper, et al.
Clinical Hemorheology and Microcirculation|September 6, 2013
Influence of endurance training and marathon running on red cell deformability in HIV patientsBasit Ahmad, Katharina Glufke, Marijke Grau, et al.
Clinical Pharmacokinetics|May 23, 2019
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 UpdateElise J Smolders, Anouk M E Jansen, Peter G J Ter Horst, et al.
BMC Infectious Diseases|December 17, 2009
Hepatic profile analyses of tipranavir in Phase II and III clinical trialsJaromir Mikl, Mark S Sulkowski, Yves Benhamou, et al.
Plos One|June 1, 2013
Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patientsLars Peters, Amanda Mocroft, Vincent Soriano, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 6, 2014
Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART studyLars Peters, Jacqueline Neuhaus, Daniel Duprez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2020
Clinically Significant Lower Elvitegravir Exposure During the Third Trimester of Pregnant Patients Living With Human Immunodeficiency Virus: Data From the Pharmacokinetics of ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) NetworkVera Bukkems, Coca Necsoi, Carmen Hidalgo Tenorio, et al.
Pageof 8